Hematologic complications in a patient with Glycine soja polyagglutination following fresh frozen plasma transfusion

1.Horn KD. The classification, recognition and significance of polyagglutination in transfusion medicine. Blood Rev 1999;13:36–44.10.1016/S0268-960X(99)90021-8Search in Google Scholar

2.Beck ML. Red blood cell polyagglutination: clinical aspects. Semin Hematol 2000;37:186–96.10.1016/S0037-1963(00)90043-XSearch in Google Scholar

3.Eder AF, Manno CS. Does red-cell T activation matter? Br J Haematol 2001:114:25–30.10.1046/j.1365-2141.2001.02886.x11472340Search in Google Scholar

4.Rickard KA, Robinson RJ, Worlledge S. Acute acquired haemolytic anaemia associated with polyagglutination. Arch Dis Child 1969;44:102–5.10.1136/adc.44.233.10220202134237145Search in Google Scholar

5.Wang Q, Liu D, Bai Y. T-cryptantigen (TCA) activation in severe pneumonia complicated with multiple organ failure. Transfus Apheresis Sci 2010;43:361–4.10.1016/j.transci.2010.10.00821075688Search in Google Scholar

6.Bird T, Stephenson J. Acute haemolytic anaemia associated with polyagglutinability of red cells. J Clin Pathol 1973;26:868–70.10.1136/jcp.26.11.8684779054766197Search in Google Scholar

7.Levene C, Sela R, Blat J, et al. Intravascular [correction of intracellular] hemolysis and renal failure in a patient with T polyagglutination. Transfusion 1986;26:243–5.10.1046/j.1537-2995.1986.26386209379.x3705141Search in Google Scholar

8.Cochran J, Panzarino V, Maes L, et al. Pneumococcus-induced T-antigen activation in hemolytic uremic syndrome and anemia. Pediatric Nephrol 2004;19:317–21.10.1007/s00467-003-1382-z14714171Search in Google Scholar

9.Hopkins C, Yuan S, Lu Q, et al. A severe case of atypical hemolytic uremic syndrome associated with pneumoccal infection and T activation treated successfully with plasma exchange. Transfusion 2008;48:2448–52.10.1111/j.1537-2995.2008.01871.x18673349Search in Google Scholar

10.Boralessa H, Modi N, Cockburn H, et al. RBC T activation and hemolysis in a neonatal intensive care population: implications for transfusion practice. Transfusion 2002;42:1428–34.10.1046/j.1537-2995.2002.00237.x12421215Search in Google Scholar

11.Ramasethu J, Luban N. T activation. Br J Haematol 2001;112:259–63.10.1046/j.1365-2141.2001.02301.xSearch in Google Scholar

12.Crookston KP, Reiner AP, Cooper LJN. RBC T activation and hemolysis: implications for pediatric transfusion management. Transfusion 2000;40:801–12.10.1046/j.1537-2995.2000.40070801.xSearch in Google Scholar

13.Bird GWG. Lectins in immunohematology. Transfusion Med Rev 1989;3:55–62.10.1016/S0887-7963(89)70068-7Search in Google Scholar

14.Wang LY, Chan YS, Chang FC, et al. Thomsen-Friedenreich activation in infants with necrotizing enterocolitis in Taiwan. Transfusion 2011;51:1972–6.10.1111/j.1537-2995.2011.03106.x21414006Search in Google Scholar

15.Eversole M, Nonemaker B, Zurek K, et al. Uneventful administration of plasma products in a recipient with T-activated red cells. Transfusion 1986;26:182–5.10.1046/j.1537-2995.1986.26286152912.x2869600Search in Google Scholar

16.Fung MK, Grossman BJ, Hillyer CD, et al. AABB technical manual. 18th ed. Bethesda, MD: AABB, 2014.Search in Google Scholar

17.Buskila D, Levene C, Bird GWG. Polyagglutination in hospitalized patients: a prospective study. Vox Sang 1987;52:99–102.10.1111/j.1423-0410.1987.tb03000.x3496714Search in Google Scholar

18.Leger R, Lines E, Cunningham K, Garratty G. A new form of polyagglutination related to Cad. Immunohematology 1996;12:69–71.10.21307/immunohematology-2019-749Search in Google Scholar